Gossamer Bio, Inc. (GOSS) Q4 2024 Annual Earnings
GOSS·Reported March 13, 2025·Before market open
Gossamer Bio, Inc. reported Q4 2024 revenue of $9.4M, beat analyst consensus of $6.8M by $2.5M. Diluted EPS came in at $-0.15, beat the $-0.17 consensus by $0.02.
Revenue
$9.4Mbeat by $2.5M
Consensus: $6.8MDiluted EPS
$-0.15beat by $0.02
Consensus: $-0.17
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Gossamer Bio, Inc.'s Q4 2024 earnings report.
Gossamer Bio, Inc. (GOSS) reported Q4 2024 earnings on March 13, 2025 before market open.
Gossamer Bio, Inc. reported revenue of $9.4M and diluted EPS of $-0.15 for Q4 2024.
Revenue beat the consensus estimate of $6.8M by $2.5M. EPS beat the consensus estimate of $-0.17 by $0.02.
You can read the 10-K periodic report (0001728117-25-000021) directly on SEC EDGAR. The filing index links above go to sec.gov.